AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2008
Mar 25, 2008
30786_dirs_2008-03-25_124eb807-2445-47b8-8338-8d9625151abd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2007-02-06
Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-02-06 | Incentive Stock Option (right to buy) | $31.77 | M | 7482 | Disposed | 2007-02-06 | Bio-Rad B Common Stock (7482) | Direct |
| 2007-02-06 | Non-Qualified Stock Option (right to buy) | $28.88 | M | 446 | Disposed | 2012-02-06 | Bio-Rad B Common Stock (446) | Direct |
Footnotes
F1: A total number of 7,928 shares exercised on 2/6/2007 was originally reported as 100% acquired pursuant to an exercise of an incentive stock option with an exercise price of $31.77. Of the total originally reported, 446 shares were actually acquired pursuant to an exercise of a non-qualified stock option with an exercise price of $28.88 and 7,482 were actually acquired pursuant to an exercise of an incentive stock option with an exercise price of $31.77.
F2: The option vested over five years at 20% per year beginning one year from the grant date which was 2/6/2002.